ÀÏÀÚ ÆÄÀÏ Á¦¸ñ ±â°ü¸í
08-04    [dz»ê (103140)] Valuation ¸Å·Â ºÎ°¢ À§ÇØ management risk ¿ÏÈ­.. »ï¼ºÁõ±Ç
08-04    [È£ÅڽŶó (008770)] È£ÅÚÀº ¸ÅÃâ Áõ°¡, ¸é¼¼´Â ¼öÀͼº °³¼± »ï¼ºÁõ±Ç
08-04    [F&F (383220)] 2Q26 review: ÀϽÃÀû ºÎÁø, ¹æÇ⼺Àº ±×´ë·Î »ï¼ºÁõ±Ç
08-04    [´ëÇÑÀ¯È­ (006650)] 2Q26 review - Àç°íÈ¿°ú Á¦¿Ü ½Ã È­ÇÐ ÈæÀÚ.. »ï¼ºÁõ±Ç
08-04    ¹Ì±¹ ¸¶°¨½ÃȲ : ºòÅ×Å© ¼±Àü ÈûÀÔ¾î »ó½Â ¸¶°¨ »ï¼ºÁõ±Ç
08-04    [LGÈ­ÇÐ (051910)] 2Q26 review - ¿¹»óº¸´Ù °­ÇÑ ½ÇÀû ½ÃÇö »ï¼ºÁõ±Ç
08-04    [¿¡ÄÚÇÁ·Îºñ¿¥ (247540)] À¯·´³» ¼öÁÖ¿Í ´ÏÄÌ Á¦·Ã¼Ò °¡µ¿¿¡ °Å´Â.. »ï¼ºÁõ±Ç
08-04    <¿ù°£Àü¸Á - 2026.08> ÄöÆ® ¸ðµ¨ Ãßõ Á¾¸ñ - 2026³â 8¿ù: ½ÃÀå .. »ï¼ºÁõ±Ç
08-04    <¿ù°£Àü¸Á - 2026.08> Çѱ¹ Áõ½Ã Àü¸Á°ú Àü·«: ¡®26³â 8¿ù: ±Û·Î.. »ï¼ºÁõ±Ç
08-04    [È¿¼ºÁß°ø¾÷ (298040)] ±Þ°ÝÈ÷ ½×¿© °¡´Â ¼öÁÖ »ï¼ºÁõ±Ç
08-04    [ÇÑÈ­¿¡¾î·Î½ºÆäÀ̽º (012450)] ¹ë·ù¿¡ÀÌ¼Ç ¸Å·Â°ú ¸ð¸àÅÒÀ» µÎ·ç.. »ï¼ºÁõ±Ç
08-04    [DL E&C (375500)] 2Q review: Beats expectations once again »ï¼ºÁõ±Ç
08-04    [Lotte Fine Chemical (004000)] 2Q review; valuation becoming.. »ï¼ºÁõ±Ç
08-04    [Medtech/Cosmetics] Pay attention after 2Q earnings releases »ï¼ºÁõ±Ç
08-04    [ÆÄ»ý¸Æ¶ô] ¹Ì±¹µµ Áֽļ±¹°½ÃÀå ¿­·È´Ù: CME °³º°Áֽļ±¹°½ÃÀå »ï¼ºÁõ±Ç
Àüü : 608  Ã³À½     ÀÌÀü    [1] [2] [3] [4] [5]    ´ÙÀ½    ³¡À¸·Î 

Ȩ > ¸®¼­Ä¡Á¤º¸ > ÃֱٰԽù°